Mey Capital Matrix

Mey Capital Matrix is a German venture capital firm specializing in high-growth life-science startups. The firm focuses on sectors such as Med-Tech, Health-Tech, and Bio-Tech, aiming to support innovative companies that contribute to advancements in healthcare and medicine.

Established in 2010, Mey Capital Matrix has a history of investing in companies involved in personalized medicine, medical diagnostics, and therapeutics. Their portfolio includes notable companies like ConoGenetix Biosciences, GNA Biosolutions, iThera Medical, Soluventis, and SpheroTec. The firm typically invests between €100,000 and €1.5 million, targeting stages from Seed to Late Stage.

With a disciplined investment approach and an emphasis on risk management, Mey Capital Matrix evaluates opportunities in both public and private markets. They aim to support strategic wealth stewardship and intergenerational capital transfer, contributing to the growth and success of their portfolio companies in the life-science sector.